Novartis AG Stock Swiss Exchange
Stocks
CH0012005267
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 10-03 | Healthcare Stocks Fall Slightly -- Healthcare Roundup | DJ |
| 10-02 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
| Market Cap | 267B 237B 221B 202B 380B 25,634B 384B 2,676B 1,037B 13,105B 1,001B 979B 42,057B | P/E 2026 * |
19.8x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 298B 265B 247B 225B 425B 28,653B 429B 2,991B 1,159B 14,648B 1,119B 1,095B 47,010B | EV / Sales 2026 * |
5.17x | EV / Sales 2027 * | 4.8x |
| Free-Float |
91.66% | Yield 2026 * |
3.09% | Yield 2027 * | 3.23% |
Last Transcript: Novartis AG
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.76% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.69B 51.26B 47.84B 43.6B 82.24B 5,546B 83B 579B 224B 2,835B 217B 212B 9,099B | 61.43B 54.58B 50.95B 46.44B 87.58B 5,906B 88.39B 617B 239B 3,019B 231B 226B 9,690B |
| Net income | 14.23B 12.64B 11.8B 10.75B 20.28B 1,368B 20.47B 143B 55.33B 699B 53.42B 52.26B 2,244B | 15.79B 14.03B 13.1B 11.94B 22.51B 1,518B 22.72B 158B 61.41B 776B 59.29B 58B 2,491B |
| Net Debt | 31.4B 27.9B 26.04B 23.74B 44.77B 3,019B 45.18B 315B 122B 1,543B 118B 115B 4,953B | 28.22B 25.07B 23.4B 21.33B 40.23B 2,713B 40.6B 283B 110B 1,387B 106B 104B 4,451B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
